AMRN Amarin Corporation plc

NASDAQ
$13.20

Amarin Corporation plc (AMRN) is expected to report earnings on October 30, 2026, before the market open. The consensus earnings estimate is a loss of $0.28 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -5.6% since its last earnings release on July 29, 2026.

Amarin Corporation plc Beat Consensus Estimates
Wednesday, July 29, 2026 · 7:00 AM ET
Earnings Date
3rd Quarter, Sep 2026
Oct 30
Friday · 7:00 AM ET
Earnings Whisper
-
vs ($0.28)
Rev est $45.35M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $14.06

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Amarin Corporation plc

Amarin Corp PLC is a biopharmaceutical company with expertise in lipid science. The Company is engaged in commercialization and development of therapeutics to improve cardiovascular health.

Sector

Healthcare

Industry

Drug Delivery

Charts powered in part by Lightweight Charts™ by TradingView.